Jian Wang

Dr. Jian Wang

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JWJian Wang
Jian Wang
XYXin Yan
Xin Yan
WFWei Feng
Wei Feng
QWQingting Wang
Qingting Wang
WSWenhua Shi
Wenhua Shi
MLManxiang Li
Manxiang Li
Sphingosine-1-phosphate (S1P), a natural multifunctional phospholipid, is highly increased in plasma from patients with pulmonary arterial hypertension (PAH) and mediates proliferation of pulmonary artery smooth muscle cell (PASMC) by activating Notch3 signaling pathway. However, the mechanisms underpinning S1P-mediated induction of PASMC proliferation remain unclear. In this study, using biochemical and molecular biology approaches, RNA-interference and gene expression analyses, 5'-Ethynyl-2'-deoxyuridine (EdU) incorporation assay and 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay, we demonstrated that S1P promoted the activation of STAT3 through sphingosine-1-phosphate receptor 2 (S1PR2), and subsequently upregulated the expression of the microRNA miR-135b, which further reduced the expression of E3 ubiquitin ligase β-transduction repeat-containing protein (β-TrCP) and led to a reduction in YAP ubiquitinated degradation in PASMC. YAP is the core effector of Hippo pathway and mediates the expression of particular genes. The accumulation of YAP further increased the expression and activation of Notch3, and ultimately promoted the proliferation of PASMC. In addition, we showed that pre-blocking S1PR2, prior silencing STAT3, miR-135b or YAP, and prior inhibition of Notch3 all attenuated S1P-induced PASMC proliferation. Taken together, our study indicates that S1P stimulates PASMC proliferation by activation of S1PR2/STAT3/miR-135b/β-TrCP/YAP/Notch3 pathway, and our data suggest that targeting this cascade might have potential value in ameliorating PASMC hyperproliferation and benefit PAH.

2 April 2021 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
QZQianqian Zhang
Qianqian Zhang
WLWenge Li
Wenge Li
YZYanting Zhu
Yanting Zhu
QWQingting Wang
Qingting Wang
CZCui Zhai
Cui Zhai
MLManxiang Li
Manxiang Li

9 June 2022 in Canadian Respiratory Journal
Verified
Journal Article
Open access
PDF file
YQYuanjie Qiu
Yuanjie Qiu
YWYan Wang
Yan Wang
NSNirui Shen
Nirui Shen
QWQingting Wang
Qingting Wang
LCLimin Chai
Limin Chai
MLManxiang Li
Manxiang Li
Background. Chronic obstructive pulmonary disease (COPD) is a common chronic disease. Progression is further exacerbated by the coexistence of cardiovascular disease (CVD). We aim to construct a diagnostic nomogram for predicting the risk of coexisting CVD and a prognostic nomogram for predicting long-term survival in COPD. Methods. The 540 eligible participants selected from the NHANES 20052010 were included in this study. Logistic regression analysis was used to construct a diagnostic nomogram for the diagnosis of coexisting CVD in COPD. Cox regression analyses were used to construct a prognostic nomogram for COPD. A risk stratification system was developed based on the total score generated from the prognostic nomogram. We used C-index and ROC curves to evaluate the discriminant ability of the newly built nomograms. The models were also validated utilizing calibration curves. Survival curves were made using the KaplanMeier method and compared by the Log-rank test. Results. Logistic regression analysis showed that gender, age, neutrophil, RDW, LDH, and HbA1c were independent predictors of coexisting CVD and were included in the diagnostic model. Cox regression analysis indicated that CVD, gender, age, BMI, RDW, albumin, LDH, creatinine, and NLR were independent predictors of COPD prognosis and were incorporated into the prognostic model. The C-index and ROC curves revealed the good discrimination abilities of the models. And the calibration curves implied that the predicted values by the nomograms were in good agreement with the actual observed values. In addition, we found that coexisting with CVD had a worse prognosis compared to those without CVD, and the prognosis of the low-risk group was better than that of the high-risk group in COPD. Conclusions. The nomograms we developed can help clinicians and patients to identify COPD coexisting CVD early and predict the 5-year and 10-year survival rates of COPD patients, which has some clinical practical values.

26 June 2020 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
LCLimin Chai
Limin Chai
WFWei Feng
Wei Feng
ZCZhai Cui
Zhai Cui
WSWenhua Shi
Wenhua Shi
JWJian Wang
Jian Wang
MLManxiang Li
Manxiang Li
Background In recent years, many studies have discovered that cystatin C (Cys C) may play an important role in respiratory diseases, especially in chronic obstructive pulmonary disease (COPD). However, the findings of these studies were inconsistent. This systematic review and meta-analysis aimed to assess the relationship between serum Cys C and COPD. Methods We conducted a systematic literature search in PubMed, Embase, Web of Science, Wanfang databases, and the China National Knowledge Infrastructure. The standardized mean difference (SMD), Fisher's Z-value and 95% confidence interval (CI) were calculated to investigate the effect sizes. Subgroup analyses were performed on disease status, ethnicity, assay method, and study design. Sensitivity was performed, and publication bias was assessed. Results A total of 15 studies, including 4079 COPD patients and 5949 controls, were included in this meta-analysis. The results showed that serum Cys C levels in patients with COPD were significantly higher than those in controls (SMD = 0.99, 95% CI =0.62-1.37,P < 0.001), especially in AECOPD (SMD = 1.59, 95% CI =1.05-2.13,P < 0.001), and there were statistically different among AECOPD and SCOPD (SMD = 0.35, 95% CI =0.10-0.59,P = 0.005). The serum Cys C levels were negatively correlated with FEV1%pre (Z = - 0.45, 95%CI = -0.58--0.32,P = 0.011) and FEV1/FVC (Z = - 0.32, 95%CI = -0.50--0.14,P = 0.006). The serum Cys C levels were independent of ethnicity, assay method, and study design. Conclusion Serum Cys C levels were associated with COPD and COPD exacerbation, and they were inversely correlated with FEV1%pre and FEV1/FVC.

12 March 2021 in Biomarkers in Medicine
Verified
Journal Article
Closed access
QWQingting Wang
Qingting Wang
QZQianqian Zhang
Qianqian Zhang
JWJian Wang
Jian Wang
WFWei Feng
Wei Feng
YCYuqian Chen
Yuqian Chen
MLManxiang Li
Manxiang Li
Aim: Long noncoding RNA (lncRNA) noncoding RNA activated by DNA damage (NORAD) is widely investigated in different tumors. Our meta-analysis intends to assess the prognostic and clinicopathological...